Baillie Gifford & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,687
| Closed | -$14.1K | – | 312 |
|
|
2023
Q1 | $14.1K | Hold |
1,687
| – | – | ﹤0.01% | 372 |
|
|
2022
Q4 | $19.4K | Hold |
1,687
| – | – | ﹤0.01% | 351 |
|
|
2022
Q3 | $21K | Hold |
1,687
| – | – | ﹤0.01% | 324 |
|
|
2022
Q2 | $18K | Hold |
1,687
| – | – | ﹤0.01% | 349 |
|
|
2022
Q1 | $27K | Buy |
1,687
+187
| +12% | +$2.99K | ﹤0.01% | 328 |
|
|
2021
Q4 | $21K | Hold |
1,500
| – | – | ﹤0.01% | 369 |
|
|
2021
Q3 | $22K | Buy |
+1,500
| New | +$22K | ﹤0.01% | 356 |
|